An in vivo model to evaluate donor-dependent cytokine release in response to single-agent or combination immune-oncology therapies.

3114Background: Although immune-oncology therapies such as checkpoint inhibitor, bi-specific antibody and CAR-T cell therapies are successfully used for cancer therapy, they can have very severe ad...